Georgetown Lombardi Announces New Office for Global Oncology
(November 20, 2020) — Responding to the need for a truly international approach to decreasing the extreme global disparities in cancer care, control and prevention, Georgetown Lombardi Comprehensive Cancer Center recently announced the formation of an Office for Global Oncology.
“The mission of this office will be to address global cancer disparities in surveillance, screening, diagnosis, treatment, survivorship, and prevention,” said Louis M. Weiner, MD, director of Georgetown Lombardi. “New faculty recruitment to bolster this mission is one of our highest priorities, together with identifying and exploiting opportunities for extramural and philanthropic support.”
The new office will be led by Chris Loffredo, PhD, professor of oncology and biostatistics, bioinformatics and biomathematics at Georgetown University School of Medicine and leader of Georgetown Lombardi’s cancer prevention and control program. Though he will be stepping down as program leader, Loffredo will continue to serve in a major role in the program.
“In this new role, Chris will engage with Georgetown Lombardi members across the consortium, encompassing all of our research and clinical programs, and will seek the input and active participation of all sectors of the university that are engaged in global health, particularly Georgetown's Global Health Initiative,” Weiner said. “I have every confidence in Chris’ ability to lead this new effort, and encourage everyone's support to make it a success.”
During his distinguished career in global oncology research and training, Loffredo has studied the epidemiology of liver and bladder cancer in Egypt for 20 years, developed infrastructure and human resources for international tobacco control, built capacity for biorepository-enabled research on a cohort of 25,000 plutonium workers and their families in Russia, and established a decade-long study of liver and bile duct cancers in Thailand.
“Establishing the Office of Global Oncology is an exciting new development for Lombardi’s long-standing commitment to global health,” said John T. Monahan, JD, senior advisor for global health to the president of Georgetown University and senior scholar at the O’Neill Institute for National and Global Health Law. “Appointing a world-class leader like Dr. Chris Loffredo as its first director will help advance Georgetown’s mission for improving care and reducing disparities for populations suffering from cancer around the world.”
“I began my career as a cancer researcher in global oncology and never lost my passion for it,” Loffredo said. “What an exciting opportunity to work with my colleagues across the cancer center and across the university to engage and collaborate with people around the world who are committed to reducing the burden of cancer. Words can’t express how much I am looking forward to this new mission.”
-
Georgetown Lombardi Announces New Office for Global Oncology
(November 20, 2020) — Responding to the need for a truly international approach to decreasing the extreme global disparities in cancer care, control and prevention, Georgetown Lombardi Comprehensive Cancer Center recently announced the formation of an Office for Global Oncology. “The mission of this office will be to address global cancer disparities in surveillance, screening, […]
Category: Lombardi Stories
-
Analyzing Tumors in Real Time to Detect Metastatic Cells Could Aid in Treatment
(November 12, 2020) — Identifying cells that metastasize from the primary tumor to other sites in the body, thereby expanding their lethality, has been a goal of scientists for years. If researchers knew more about what gives metastatic cells their ability to spread and grow throughout the body, there would be a better chance to […]
Category: Lombardi Stories
-
Immunotherapy Combo Halts Rare, Stage 4 Sarcoma in Teen
NUTLEY, NJ (October 14, 2020) — A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment had a “rapid and complete response” to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center […]
Category: News Release
-
BellRinger Bike Ride Announcement Concludes ‘Five Days with Lombardi’
(October 9, 2020) — As part of the celebration of its 50th anniversary during the week of Oct. 5-9, Georgetown Lombardi rolled out plans to hold the inaugural BellRinger Bike Ride in September 2021. “BellRinger will be a cycling event that brings together dedicated individuals and teams focused on ending cancer,” said Louis Weiner, MD, […]
Category: Lombardi Stories
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
(September 14, 2020) — Julie Shanholtz was having an uneventful summer in 2017 working full time with the same employer she’d had for the past 30 years when she developed an “odd cough” that quickly became severe, but no other symptoms. “I had always been very active and healthy — and didn’t smoke,” the 54-year-old […]
Category: Lombardi Stories
-
Georgetown Lombardi Patient Records Song with Cancer Can Rock
(August 14, 2020) — As an amateur musician, songwriting has been an outlet for decades for Seth Lucash, a patient of Michael B. Atkins, MD, deputy director at Georgetown Lombardi Comprehensive Cancer Center. “When I was about 16, I just started sitting at the piano and writing,” he said. “Writing was a very big release […]
Category: Lombardi Stories
-
First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight
(July 31, 2020) — In the field of breast screening, 3D imaging, or tomosynthesis mammography, has become the go-to screening modality over conventional digital mammography in recent years. But does 3D screening actually improve detection of — and survival from — life-threatening breast cancers, or does conventional mammography perform just as well at a lower […]
Category: Lombardi Stories
-
Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer
WASHINGTON (April 29, 2020) — Georgetown Lombardi Comprehensive Cancer Center, in collaboration with MedStar Georgetown University Hospital, has begun a study to test for specific virus antibodies in people with cancer, who are vulnerable to COVID-19. The FDA, has approved (under an emergency use authorization) only a few tests produced commercially to detect antibodies against […]
Category: News Release
-
Adding Smoking Cessation to Lung Cancer Screening Can Reduce Mortality by 14%
WASHINGTON (March 9, 2020) — Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study led by researchers at the University of Michigan and Georgetown Lombardi Comprehensive Cancer Center. The study is published […]
Category: News Release
-
Lombardi at 50: Community Outreach to Reduce Differences in Health Outcomes
(March 5, 2020) — When Georgetown Lombardi Comprehensive Cancer Center’s Office of Minority Health and Health Disparities Research was created in 2008, its associate director, Lucile Adams-Campbell, PhD — the nation’s first black female epidemiologist — had a clear vision of need about the work ahead within the community. “Georgetown can come to everyone but […]
Category: Lombardi Stories